Ratings by Truist Securities (Danielle Brill)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/10/2026 | Dianthus Therapeutics | DNTH | Maintain | Buy (N/A) |
|
Details | ||
| 6/2/2026 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 5/27/2026 | Apogee Therapeutics Inc | APGE | Maintain | Hold (N/A) |
|
Details | ||
| 5/27/2026 | Vertex | VRTX | New Coverage | Buy (N/A) |
434.52 (468.42) |
7.8% | Details | |
| 5/22/2026 | Immunovant | IMVT | Maintain | Hold (N/A) |
|
Details | ||
| 5/18/2026 | Rapport Therapeutics | RAPP | New Coverage | Buy (N/A) |
37.07 (38.88) |
4.88% | Details | |
| 5/13/2026 | Insmed | INSM | Maintain | Buy (N/A) |
|
Details | ||
| 5/13/2026 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 5/8/2026 | Harmony Biosciences Holdings Inc. | HRMY | Maintain | Hold (N/A) |
|
Details | ||
| 5/6/2026 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 4/30/2026 | Biogen | BIIB | Maintain | Hold (N/A) |
|
Details | ||
| 4/29/2026 | BridgeBio Pharma | BBIO | Maintain | Buy (N/A) |
|
Details | ||
| 4/29/2026 | WAVE Life Sciences | WVE | New Coverage | Buy (N/A) |
6.94 (6.04) |
-12.97% | Details | |
| 4/27/2026 | Biogen | BIIB | Maintain | Hold (N/A) |
|
Details | ||
| 4/13/2026 | Maze Therapeutics | MAZE | Maintain | Buy (N/A) |
|
Details | ||
| 4/13/2026 | Biogen | BIIB | Maintain | Hold (N/A) |
|
Details | ||
| 4/13/2026 | Alnylam Pharmaceuticals | ALNY | Maintain | Buy (N/A) |
|
Details | ||
| 4/13/2026 | Centessa Pharmaceuticals | CNTA | Downgrade | Hold (Buy) |
39.76 (40.50) |
1.86% | Details | |
| 4/7/2026 | Insmed | INSM | Maintain | Buy (N/A) |
|
Details | ||
| 4/2/2026 | Upstream Bio | UPB | Maintain | Buy (N/A) |
|
Details | ||
| 4/2/2026 | Immunovant | IMVT | Maintain | Hold (N/A) |
|
Details | ||
| 3/25/2026 | Maze Therapeutics | MAZE | Maintain | Buy (N/A) |
|
Details | ||
| 3/23/2026 | Apogee Therapeutics Inc | APGE | Maintain | Hold (N/A) |
|
Details | ||
| 3/17/2026 | Apogee Therapeutics Inc | APGE | New Coverage | Hold (N/A) |
71.09 (132.88) |
86.92% | Details | |
| 3/17/2026 | Climb Bio | CLYM | New Coverage | Buy (N/A) |
7.13 (12.30) |
72.51% | Details | |
| 3/17/2026 | Maze Therapeutics | MAZE | New Coverage | Buy (N/A) |
51.26 (26.41) |
-48.48% | Details | |
| 3/9/2026 | Dianthus Therapeutics | DNTH | Maintain | Buy (N/A) |
|
Details | ||
| 2/27/2026 | Disc Medicine | IRON | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2026 | BridgeBio Pharma | BBIO | Maintain | (N/A) |
|
Details | ||
| 2/24/2026 | Palvella Therapeutics | PVLA | Maintain | Buy (N/A) |
|
Details | ||
| 2/24/2026 | Harmony Biosciences Holdings Inc. | HRMY | Maintain | Hold (N/A) |
|
Details | ||
| 2/20/2026 | Harmony Biosciences Holdings Inc. | HRMY | Downgrade | Hold (Buy) |
34.39 (34.16) |
-0.67% | Details | |
| 2/17/2026 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 2/13/2026 | Alnylam Pharmaceuticals | ALNY | Maintain | Buy (N/A) |
|
Details | ||
| 2/9/2026 | Immunovant | IMVT | Maintain | Hold (N/A) |
|
Details | ||
| 2/9/2026 | Biogen | BIIB | Maintain | Hold (N/A) |
|
Details | ||
| 1/29/2026 | Centessa Pharmaceuticals | CNTA | Maintain | Buy (N/A) |
|
Details | ||
| 1/12/2026 | Insmed | INSM | Maintain | Buy (N/A) |
|
Details | ||
| 12/19/2025 | Insmed | INSM | New Coverage | Buy (N/A) |
198.46 (102.15) |
-48.53% | Details | |
| 12/15/2025 | Palvella Therapeutics | PVLA | Maintain | Buy (N/A) |
|
Details | ||
| 11/14/2025 | Jefferson Capital | JCAP | Maintain | Buy (N/A) |
|
Details | ||
| 11/10/2025 | Disc Medicine | IRON | Maintain | Buy (N/A) |
|
Details | ||
| 11/10/2025 | Palvella Therapeutics | PVLA | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2025 | Centessa Pharmaceuticals | CNTA | Maintain | Buy (N/A) |
|
Details | ||
| 10/31/2025 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 10/30/2025 | BridgeBio Pharma | BBIO | Maintain | Buy (N/A) |
|
Details | ||
| 10/30/2025 | BridgeBio Pharma | BBIO | Maintain | Buy (N/A) |
|
Details | ||
| 10/29/2025 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 10/17/2025 | Disc Medicine | IRON | Maintain | Buy (N/A) |
|
Details | ||
| 10/17/2025 | Alnylam Pharmaceuticals | ALNY | Maintain | Buy (N/A) |
|
Details | ||
| 10/14/2025 | Dianthus Therapeutics | DNTH | New Coverage | Buy (N/A) |
34.42 (87.53) |
154.3% | Details | |
| 10/14/2025 | Upstream Bio | UPB | New Coverage | Buy (N/A) |
20.08 (6.32) |
-68.53% | Details | |
| 10/14/2025 | Immunovant | IMVT | New Coverage | Hold (N/A) |
17.35 (37.62) |
116.83% | Details | |
| 10/2/2025 | Palvella Therapeutics | PVLA | Maintain | Buy (N/A) |
|
Details | ||
| 9/17/2025 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 9/15/2025 | argenx SE | ARGX | New Coverage | Buy (N/A) |
756.39 (853.40) |
12.83% | Details | |
| 9/10/2025 | BridgeBio Pharma | BBIO | Maintain | Buy (N/A) |
|
Details | ||
| 9/2/2025 | Alnylam Pharmaceuticals | ALNY | Maintain | Buy (N/A) |
|
Details | ||
| 8/20/2025 | Centessa Pharmaceuticals | CNTA | Maintain | Buy (N/A) |
|
Details | ||
| 8/15/2025 | Alnylam Pharmaceuticals | ALNY | Maintain | Buy (N/A) |
|
Details | ||
| 8/1/2025 | Alnylam Pharmaceuticals | ALNY | Maintain | Buy (N/A) |
|
Details | ||
| 7/31/2025 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 7/21/2025 | Biogen | BIIB | New Coverage | Hold (N/A) |
124.99 (197.19) |
57.76% | Details | |
| 7/21/2025 | Tectonic Therapeutics Inc. | TECX | New Coverage | Buy (N/A) |
21.91 (30.59) |
39.62% | Details | |
| 7/21/2025 | Centessa Pharmaceuticals | CNTA | New Coverage | Buy (N/A) |
15.69 (39.76) |
153.41% | Details | |
| 7/21/2025 | Disc Medicine | IRON | New Coverage | Buy (N/A) |
57.77 (70.45) |
21.95% | Details | |
| 7/21/2025 | Jefferson Capital | JCAP | New Coverage | Buy (N/A) |
16.70 (17.51) |
4.85% | Details | |
| 7/21/2025 | Neurocrine Bio. | NBIX | New Coverage | Buy (N/A) |
132.02 (161.44) |
22.28% | Details | |
| 7/21/2025 | Palvella Therapeutics | PVLA | New Coverage | Buy (N/A) |
29.51 (118.68) |
302.17% | Details | |
| 7/21/2025 | Alnylam Pharmaceuticals | ALNY | New Coverage | Buy (N/A) |
320.53 (288.18) |
-10.09% | Details | |
| 7/21/2025 | BridgeBio Pharma | BBIO | New Coverage | Buy (N/A) |
46.51 (68.63) |
47.56% | Details | |
| 7/21/2025 | Harmony Biosciences Holdings Inc. | HRMY | New Coverage | Buy (N/A) |
35.20 (34.16) |
-2.95% | Details |
